Background

The Herpesviridae family comprises over 100 viruses that can infect a wide variety of species of at least two animal phyla, the Chordata (mammals, birds, fishes, reptiles, and amphibians) and the Mollusca (oysters), with each member consisting of an enveloped icosahedral capsid containing a proteinaceous tegument and a dsDNA genome [1]. The Herpesviridae family is divided into three subfamilies (Alphaherpesvirinae, Betaherpesvirinae, and Gammaherpesvirinae) based on their biological properties and genome sequences [2]. The Alphaherpesvirinae subfamily contains HSV-1/2; the Betaherpesvirinae subfamily contains human cytomegalovirus (HCMV) and human herpesvirus-6A and 6B (HHV-6A and -6B) [3]; and the Gammaherpesvirinae subfamily contains Kaposi’s sarcoma-associated herpesvirus (KSHV), Epstein-Barr virus (EBV) and murine gammaherpesvirus 68 (MHV68) [4]. A characteristic feature that is common to all herpesvirus infections is the establishment of latent infections, a state from which the virus can be reactivated and result in recurring disease [2].

Host shutoff, on the one hand, means directly reducing the levels of cellular mRNAs or preventing their association with ribosomes and translation initiation factors that can facilitate the translation of viral mRNAs [5]. A common theme is that different viruses encode a few proteins that block host gene expression by promoting global mRNA degradation, such as the virion host shutoff (VHS) protein of HSV-1/2 [6], SOX and its homologs in gammaherpesviruses [7, 8], Nsp1 of SARS-coronaviruses [9] and PA-X from influenza A virus [10]. In cells, each protein targets host RNA polymerase II (Pol II) transcripts for cleavage and requires host Xrn1 to complete RNA degradation, although the mechanism of targeting and the position of the primary cleavage differs [11, 12]. On the other hand, HSV-1 ICP27 interacts with splicing proteins and inhibits cellular pre-mRNA splicing early after infection, resulting in a decrease in the splicing of products into cellular translation machinery; therefore, HSV-1 ICP27 also contributes to the shutoff of host protein synthesis [13, 14]. However, betaherpesviruses, such as HCMV, do not shut off host macromolecular synthesis [15]. In this review, we will discuss host shutoff mechanisms of HSV-1 and members of the Gammaherpesvirinae subfamilies and their roles in immune evasion.

Main text

mRNA processing

HSV infection leads to suppression of cellular protein synthesis through at least two distinct inhibitory pathways. In the first pathway, delivery of the VHS protein, encoded by the HSV UL41 gene, into the cytoplasm after fusion of the viral envelope with the host cell membrane. This event leads to an increase in the global mRNA degradation rate in the cytoplasm, and the precipitous decrease in the levels of most host mRNAs curtails the synthesis of the corresponding proteins [16]. VHS and its homologs are only present in the genomes of Alphaherpesvirinae subfamily members, and as an endoribonuclease with similar substrate specificity to RNase A, VHS triggers the rapid shutoff of host cell protein synthesis and disrupts preexisting polyribosomes [17]. The pseudorabies virus (PRV) UL41 gene-encoding protein is the homologue of the HSV UL41 protein and has a similar shutoff function [18]. In contrast, the varicella-zoster virus (VZV) open reading frame 17 (ORF17) protein, a homolog of HSV UL41 protein, can also induce RNA cleavage, but to a substantially lesser extent than HSV-1 VHS and has no major function in the VZV-mediated delayed host shutoff [19]. Interestingly, ORF17 protein is crucial for VZV replication at 37 °C [20]. Thus, VHS likely plays a fundamental and conserved role in the biology of infections caused by alphaherpesviruses, but its effect in different viral infections is distinct. In addition, VHS reduces dsRNA levels by reducing the potential for generating dsRNA and directly removing dsRNA after its formation [21]. This novel function would be important in immune evasion and may exist in other alphaherpesviruses.

Second, HSV-1 ICP27 has role in pre-mRNA polyadenylation and splicing that inhibits host mRNA maturation [22]. Eukaryotic pre-mRNAs are processed after synthesis in the nucleus and then translated in the cytoplasm, although an unusual feature of HSV-1 transcripts is that the majority are intronless (except ICP22, ICP0, ICP47, UL15, LAT and gC) and thus do not interact with the splicing machinery [23]. ICP27 interacts with and recruits cytoplasmic kinase SR protein kinase 1 (SRPK1) to the nucleus to inhibit host cell splicing, after which the unspliced host mRNAs in the nucleus cannot be exported to the cytoplasm for translation, leading to host protein synthesis shutoff [24]. Recently, ICP27 has been shown to inhibit the splicing of specific introns and promote the use of alternative 5′ splice sites (ss). Furthermore, ICP27 targets high GC content and cytosine-rich sequences that are similar to those of HSV genes spared by the VHS, possibly promoting virus-induced host shutoff [25]. In addition, transcription termination affects mRNA production and translation, and HSV-1 induces the disruption of transcription termination of host genes [26]. HSV-1 ICP27 was recently shown to block the transcription termination of host genes by inhibiting mRNA 3′ processing. Furthermore, ICP27 can act as a sequence-dependent activator of mRNA 3′ processing to promote efficient transcription termination of viral transcripts, indicating that HSV-1 ICP27 plays an important role in host shutoff [27].

Similar to alphaherpesviruses, gammaherpesviruses promote host shutoff by inducing widespread cellular mRNA degradation during the early lytic phase of viral infection [7, 8, 28]. The KSHV host shutoff RNase is not homologous to VHS, but is the alkaline exonuclease ORF37 protein, also known as SOX, a member of the PD(D/E) XK restriction endonuclease superfamily. While its homologs in other gammaherpesviruses are also host shutoff factors, SOX homologs are also present in other herpesviruses, including those such as HCMV that fail to inhibit host gene expression [11]. However, the SOX protein and its homologs (muSOX and BGLF5) in gammaherpesviruses possess both exonucleolytic DNase and RNase activities. These activities are genetically separable, and the shutoff activity does not require DNase activity, although the processing of DNA and RNA substrates requires the same catalytic center [29].

In contrast to VHS, SOX is not packaged in virion particles and is expressed with early kinetics [8]. SOX targets a degenerate motif to degrade many mRNAs in the cytoplasm [29, 30]. In addition, it induces nascent cellular mRNAs to undergo poly(A) tail extension (hyperadenylation), which prevents the export of nascent nuclear messages [31, 32]. muSOX continues to accumulate during the late stages of the viral replicative cycle and broadly targets viral mRNAs from all three kinetic classes, which generally results in a decrease in relevant viral protein levels at each class [33]. Selective inactivation of the mRNA degradation activity of muSOX results in altered protein composition of progeny virions, which ultimately impacts subsequent rounds of infection by favoring lytic cycle entry over latency [33, 34]. The deletion of BGLF5 results in the accumulation of several viral proteins during EBV infection and causes nuclear egress defects [35]. In addition, SOX and its homologs possess intrinsic RNase activity, but they cannot solely account for host shutoff in vitro [36].

Although a wide variety of mRNAs are degraded by viral endonucleases, some mRNAs contain a SOX resistance element (SRE) in their 3′ untranslated region (UTR) that prevents their degradation by multiple viral endonucleases, such as C19ORF66, IL-6 and DNA damage-inducible gene 45 (GADD45β) [37,38,39]. A number of ribonucleoprotein complex proteins are involved in this process, for example, nucleolin (NCL) binds the IL-6 mRNA 3’UTR and eIF4H to protect IL-6 mRNA from degradation [37], although a detailed mechanism how SREs promote the escape of mRNAs from viral endonucleases mediated decay remains unknown. Apoptosis enhancing nuclease (AEN) mRNA is also spared from SOX-mediated decay without a clear protective element in its sequence [40], and VHS cannot degrade tristetraprolin (TTP) [41]. These results suggest that multiple mechanisms can apparently promote mRNA escape. However, with the exception of the SREs, whether some mRNAs involved in the viral or cellular life cycle are spared viral endonuclease-mediated decay remains unknown, and these spared mRNAs may be needed for viral gene expression or to activate the immune response to inhibit viral replication.

Downregulation of host mRNA translation

In eukaryotes, a key factor in translation control is eukaryotic translation initiation factor 2 (eIF2). The α subunit of eIF2 is phosphorylated by a number of kinases, including protein kinase (PKR), PKR-like endoplasmic reticulum kinase (PERK), general control nonderepressible-2 kinase (GCN2), and heme-regulated eIF2a kinase (HRI), resulting in translation arrest and, ultimately, a general translational shutoff [42]. This effect is harmful to viruses that need the host translation machinery to synthesize viral proteins. However, VHS blocks PKR activation via its endoribonuclease activity during the immediate onset of viral infection to counteract the activation of eIF2 by kinases, and VHS-defective viruses induce the phosphorylation of eIF2α [43, 44]. In addition, HSV-1 ICP27 inhibits PKR binding to dsRNA and its autophosphorylation but has no direct effect on eIF2α phosphorylation, potentially by only causing conformational changes in PKR [45].

In vitro-translated VHS exhibits endonuclease activity with no selectivity. Nevertheless, VHS shows a strong preference for mRNAs in vivo [46], degrading the 5′ end of mRNAs prior to the 3′ end, and is targeted to regions of translation initiation through its interaction with eIF4H [47]. Interestingly, several VHS mutations that abrogate its ability to bind eIF4H also abolish its mRNA-degrading activity, even though the mutant proteins retain endonuclease activity. Interestingly, several point mutations that abolish its mRNA-degrading activity also abrogate its ability to bind eIF4H, the depletion of which impedes VHS-mediated degradation [48]. Furthermore, eIF4H switches from cytoplasmic to nuclear localization during the initial shutdown of translation after viral infection [49]. However, the interaction between VHS and eIF4B or eIF4F is not sufficient to induce mRNA decay [50]. Alternatively, the targeting of VHS may depend upon its ability to interact with translation factors, whether the preferred cleavage sites are in regions of translation initiation or not [51]. However, VHS cleaves mRNAs close to AU-rich elements (AREs) in their 3′ UTRs by interacting with tristetraprolin (TTP) [52]. The internal ribosome entry site (IRES) derived from encephalomyocarditis virus (EMCV) or poliovirus acts to strongly target VHS-dependent RNA cleavage events to a narrow zone located immediately 3′ to the IRES [53]. These two degradation models require neither ribosome scanning nor interaction with translation initiation factors to select the cleavage sites. Unlike VHS, SOX has no interaction with eIF4H and cosediments with 40S ribosomal subunits, depletes polysomes, and specifically recognizes mRNAs at an early stage of translation, although the factor(s) involved SOX recruitment to its mRNA targets remain unknown [32]. During MHV68 infection, because the translation factors are unlimited, the targeting of viral mRNAs during gammaherpesvirus infection is not a mechanism to redirect the translation machinery towards host genes [34].

Cytoplasmic poly (A)-binding protein (PABPC) is a predominantly cytoplasmic protein that is required for efficient translation initiation and binds to mRNA poly(A) tails to enhance mRNA stability, translation efficiency, and quality control in the cytoplasm, in part through its interactions with the eIF4G translation initiation factor [54]. During lytic HSV-1 infection, VHS, ICP27 and other viral proteins induce the translocation of PABPC from the cytoplasm to the nucleus [55,56,57]. In addition, ICP27 associates with PABP and eIF4G to promote translation initiation [58]. SOX and its homologs also relocalize PABPC into the nucleus [30, 57, 59, 60], where intranuclear PABPC accumulation leads to excessive nuclear mRNAs and a block in the nuclear export of mRNAs, resulting in restricted protein expression [57].

Boosting the expression of viral proteins

VHS directly or indirectly enhances the translation of viral mRNAs. VHS boosts the translation of viral true late mRNAs in a cell type-dependent manner and then determines the viral growth phenotype in the respective cell type, such as Hela cells [61, 62]. First, VHS refines the transition between the successive expression of viral IE, E, and late (L) genes to facilitate the turnover of all kinetic classes of viral mRNAs [63], preventing “mRNA overload” during the late stages of infection by eliminating host mRNAs and promoting the decay of viral IE and E transcripts [64]. In the absence of VHS, the half-lives of all classes of viral transcripts are dramatically increased, and the resulting accumulation of viral mRNAs overwhelms the capacity of the host translational machinery, leading to functional deficiency of the L mRNAs that are made during infection. Second, recent reports have shown that the translational defect observed for L mRNAs in the absence of VHS does not stem from one or more structural features of the affected mRNAs, since these transcripts accumulate late during infection [64]. Third, VHS is more sensitive to unspliced mRNAs than spliced mRNAs, and exon junction complexes (EJCs) may transiently protect spliced mRNAs from VHS degradation, causing a modest stimulation in translation and accumulation of spliced mRNA [65]. Thus, VHS may also enhance the expression of these viral genes depending on other functions.

To avoid multiple viral mRNAs being degraded by VHS at later times of infection in an unrestrained fashion, the viral proteins ICP27, VP13/14, VP16 or VP22 interact with and attenuate VHS RNase activity [66, 67]. Furthermore, the VP16-VP22 complex rescues the nuclear retention of VHS mRNA and the VHS-induced nuclear retention of late transcripts during HSV-1 infection, allowing for their efficient translation [67, 68]. VP13/14 stabilizes host and viral IE mRNAs and effectively blocks the degradation of E and L mRNAs, but it has no effect on the processing of AU-rich mRNAs [66, 69]. ICP27 also interacts with VHS, which may impact the stability of ARE-containing mRNAs, although this function remains controversial [70]. ICP27 and VP13/14 as nucleocytoplasmic shuttling proteins that can bind and transport RNA [71, 72], we speculate there are unknown associations between VHS, mRNA, VP13/14 and ICP27. And these interactions may also facilitate incorporation of VHS into the tegument of progeny virions. Unlike alphaherpesviruses, there are few reports regarding other viral proteins that regulate host shutoff-associated activity in gammaherpesviruses, with the exception of the EBV protein kinase BGLF4 that antagonizes BGLF5-mediated viral gene shutoff [73]. Thus, it is necessary to continue exploring the viral proteins regulate SOX or muSOX activity after gammaherpesvirus infection.

In addition, ICP27 facilitates viral RNA export by recruiting mRNA export adaptors to viral replication sites and binding intronless viral mRNAs through its RGG domain [22, 74,75,76,77,78]. ICP27 promotes expression of the full-length gC protein and tightly regulates the expression of HSV-2 monocistronic ICP34.5 mRNA by inhibiting splicing and activating a cryptic polyadenylation signal (PAS) in new introns [23]. The PRV UL54 protein is a homolog of HSV-1 ICP27 and has a drastic impact of the genome-wide expression of PRV genes, especially on the transcription of the true late genes [79]. These studies have provided insights into the crucial role of ICP27 and its homologs in selectively regulating viral mRNA nuclear export to favor viral RNA transcription and protein translation.

Immune evasion

The detection of microbial pathogens is an essential first step in mounting an innate immune response to infection. Pattern recognition receptors (PRRs) recognize pathogen-associated molecular patterns (PAMPs) and trigger the production of numerous host defense molecules, including interferons (IFNs), proinflammatory cytokines and chemokines [80]. In addition, IFNs can be classified into three groups (types I, II and III), where IFN-I (IFN-α/β) and III are crucial antiviral factors that stimulate the synthesis of a variety of antiviral effector molecules [81]. A number of innate immune mechanisms are invoked following infection, and herpesviruses in turn takes different measures to neutralize these host responses, with host shutoff proteins playing crucial roles in escaping innate immune.

VHS as an IFN-α/β resistance factor

VHS has been identified as an IFN-α/β resistance factor that is essential for viral survival. Primary murine embryonic fibroblasts (MEFs) infected with HSV-2 ΔVHS mutants were observed to produce > 50-fold more IFN-a/β than cells infected with wild-type and VHS-rescued viruses. In addition, pretreatment of MEFs with IFN-I inhibited the replication of HSV-2 ΔVHS more than that of wild-type and VHS-rescued viruses, indicating that VHS interferes with activation of the IFN-a/β-induced antiviral response. The authors further examined whether VHS interferes with key mediators of the IFN-a/β response, PKR and RNase L [82]. Furthermore, HSV-1 VHS-defective viruses have been shown to induce increased, physiologically active levels of IFN and increased amounts of ISGs. VHS-defective HSV-1 viruses have increased susceptibility to IFN in cells [44], but not in culture, and the virulence of these viruses is not restored in IFN-a/β/γ R/ mice [83]. The HSV-2 VHS protein is ~ 40-fold more active than that of HSV-1 and has a more crucial role in HSV-2 than its HSV-1 counterpart in promoting resistance to the IFN response and plays an important role in damaging the host defense mechanism. In addition, Bovine herpesvirus 1 (BHV-1) ICP27, as a potent IFN-β antagonist, interferes with the promoter activity of IFN-β1 and IFN-β3 [84].

Inhibition of cellular PRR-mediated antiviral responses

Cyclic-GMP-AMP (cGAMP) synthase (cGAS), the most recently identified cytosolic DNA sensor, plays an important role in IFN-I responses against DNA viruses, including HSV-1 and KSHV. Interestingly, HSV-1 UL41 degrades cGAS mRNAs via its RNase activity to evade the cGAS/STING-mediated DNA-sensing pathway [85]. Furthermore, ICP27 interacts with the TBK1-STING signalosome in the cytoplasm through its RGG motif to inhibit interferon regulatory factors 3 (IRF3) activation and IFN production through the cGAS-STING pathway in macrophages [86]. In addition, HSV-2 ICP27 also directly associates with IRF3 and inhibits its phosphorylation and nuclear translocation, resulting in the inhibition of IFN-β production [87].

IFI16 was identified as a DNA sensor that also signals through STING-TBK1 to detect viral DNA in both the cytoplasm and nucleus [88]. Interestingly, nuclear IFI16 can assemble inflammasomes during infection by KSHV and HSV-1, leading to the secretion of proinflammatory interleukins [89, 90]. HSV-1 rapidly blocks IFI16-mediated immune responses during infection by catalyzing its degradation, in part via the contribution of ICP0 [90]. However, ICP0 is not necessary or sufficient for the loss of IFI16 in a tumor-derived cell line, and the ICP0-independent loss of IFI16 in HeLa cells is dependent in part on VHS RNase activity [91].

TLRs and RLRs are also fundamental sensor molecules of the host innate immune system that detect conserved molecular signatures of a wide range of microbial pathogens and initiate innate immune responses via distinct signaling pathways [92]. The HSV-2 VHS protein inhibits TLR3 and RIG-I/Mda-5 as well as TLR2-mediated antiviral pathways for sensing dsRNA and effectively suppresses IFN-β antiviral responses in human vaginal epithelial cells (ECs) [93]. ICP27 also inhibits signaling downstream of the RIG-I adaptor protein MAVS and the TLR adaptor protein TRIF, while the KSHV ORF57 protein inhibits TLR3 phosphorylation [45, 94]. In addition, the EBV lytic-phase protein BGLF5 contributes to downregulation of TLR9 levels through RNA degradation [95] (Fig. 1).

Fig. 1
figure 1

Herpesvirus host shutoff-associated proteins mediate evasion of the type I IFN signaling pathway (refer to [96])

Counteracting ISGs

IFN activates the Janus kinase signal transducer and activator of transcription (JAK/STAT) signaling pathway, resulting in the downstream expression of hundreds of antiviral host effector proteins called ISGs [97, 98]. However, HSV-1 infection restricts the expression of some ISGs through various strategies. For instance, ICP27 downregulates IFN-induced STAT1 phosphorylation and promotes inhibition of STAT1 nuclear accumulation [99]. VHS partially inhibits JAK1 and STAT2 by degrading their mRNAs [100], and the VHS homolog BHV-1 UL41 protein directly binds and cleaves STAT1 mRNA [101]. In addition, VHS degrades some ISG mRNAs through its RNase activity to counteract their antiviral activity, including IFIT3 [102], viperin [103], tetherin [104], ZAP [105], and CH25h [106] (Table 1).

Table 1 Inhibition of ISGs

Inhibition of proinflammatory chemokines and cytokines

The VHS protein also suppresses proinflammatory chemokines and cytokines, such as interleukin (IL)-1β, IL-8, macrophage inflammatory protein-1α (MIP1α) [107], and alpha-thalassemia/mental retardation syndrome X-linked (ARTX), an effector of the innate immune response [108], which inhibits major histocompatibility complex (MHC) class I/II and quenches activation of some antigen-presenting dendritic cell (DC) subtypes [93]. Thus, VHS is a crucial determinant of HSV virulence. Similar to VHS, the BGLF5 and SOX proteins downregulate the expression of multiple immune components and reduce the levels of lipid antigen-presenting CD1d and HLA class I /II molecules [109]. However, because this activity is redundant with other EBV proteins that specifically combat HLA processing and transport, it appears to have only a small effect on CD8+ T cell recognition [110, 111]. Selective inactivation of muSOX mRNA degradation activity leads to a severe attenuation of MHV68 in B cells during the phase of peak latency establishment [112]. In addition, ICP27 inhibits p65 acetylation and NF-kB transcriptional activity by repressing Daxx sumoylation [113] (Table 2).

Table 2 Host shutoff-associated proteins inhibit various proinflammatory cytokines and cytokines

Suppression of the UPR

Eukaryotic cells respond to various types of stresses caused by changes in the extracellular environment, and the accumulation of unfolded and misfolded proteins in the endoplasmic reticulum (ER) causes ER stress that activates the unfolded protein response (UPR) via three ER transmembrane receptors: PERK, inositol-requiring enzyme 1 (IRE1) and activating transcription factor 6 (ATF6) [114]. The kinase activity of IRE1α leads to activation of c-Jun N-terminal kinases (JNKs) during HSV-1 infection, where ICP27 activates the stress-responsive JNKs to enhance viral replication [115]. VHS suppresses the IRE1/XBP1 signal pathway by directly reducing the accumulation of XBP1 mRNA [116]. Thus, UPR signaling clearly has an important role in immunity and inflammation [117]. The UPR can also support important antiviral responses, activate proinflammatory cytokines and cytokines [118]. Therefore, we speculate that VHS inhibits the UPR pathway to cellular resources for viral replication as well as to promote evasion of the immune response activated by UPR to ensure viral survival. However, unlike VHS, KSHV SOX protein does not affect the expression of UPR genes [119]. These results indicate that different herpesviruses have evolved distinct mechanisms to regulate the UPR to promote viral replication.

SGs disassembly

Stress granule (SG) formation can interfere with viral replication, as herpesviruses require the host translation machinery to synthesize viral proteins. Interestingly, an HSV ΔVHS mutant cannot disrupt arsenite-induced SG formation, an ability that is restored by VHS complementation, and this VHS-mediated disruption also occurs in the absence of other viral proteins [120]. Furthermore, VHS endoribonuclease activity is required to disrupt SG formation, which, in concert with Xrn1 exonuclease activity, promotes the destruction of mRNAs present in existing SGs, leading to their disassembly [121, 122]. Some reports have suggested that SGs act as platforms that sense viral molecular patterns and initiate downstream signaling to promote antiviral responses, as SGs can promote PKR activation in HSV-1 infection, although the ability of VHS to suppress IFN is unrelated to its ability to inhibit PKR activation and SG formation [121]. Furthermore, KSHV SOX also inhibits arsenite-induced SG formation, and HSV-1 ICP27 blocks the PKR/eIF2α/SG pathway to overcome host antiviral responses, an activity that its EBV homolog EB2 lacks [45]. Thus, further exploration of the relationships among of SGs, IFN and ICP27 will be very meaningful (Fig. 2).

Fig. 2
figure 2

VHS, ICP27 and SOX reduce mRNA abundance to shutoff the expression of host proteins through different strategies. VHS and SOX degrade mRNA via their RNase activity; ICP27 inhibits host pre-mRNA polyadenylation and splicing; and SOX/muSOX proteins induce nascent host mRNA hyperadenylation. In addition, these three proteins alter the localization of cytoplasmic poly (A) binding protein (PABPC), leading to limited mRNA export from the nucleus to the cytoplasm. VHS suppresses the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress, and protein kinase R (PKR) phosphorylates eukaryotic translation initiation factor 2α (eIF2α). VHS and SOX also inhibit the subsequent formation of stress granules (SGs) to favor viral replication (refer to [123])

Conclusions

Herpesviridae family members are among the most ubiquitous and successful viruses known and are thought to have coevolved with their hosts. The success of herpesviruses is due in part to their use of host shutoff mechanisms to ensure the efficient translation of viral mRNAs while constraining host protein expression. Although accumulating evidence has elucidated these protein-associated host shutoff and immune invasion mechanisms, much remains unclear regarding the biogenesis, characteristics, and adaptive responses of shutoff activity in different viral strains and various hosts. With the exception of HSV, and understanding of the UL41 proteins of other alphaherpesviruses is limited. UL41 proteins from different viruses, such as ORF17 and VHS, have different effects on viral infections. In addition, the HSV-1 VHS protein not only induces mRNA degradation, it also promotes dsRNA degradation. These results suggest that VHS homologs in other alphaherpesviruses may have another function in addition to RNase activity, which should be further explored in future studies. In particular, VHS suppresses a variety of cytokines, which leads to widespread immune shutoff, and whether other host proteins arrest VHS-induced immune shutoff for cell survival is unknown. Furthermore, the fate of AU-rich mRNAs is unknown. AREs generally promote destabilization, and VHS efficiently degrades AU-rich mRNAs by binding TTP and AU-rich mRNAs that are not resistant to SOX-induced shutoff. However, the SRE in the IL-6 mRNA 3’UTR can effectively escape viral endonucleases, and this region also contains AREs. The mechanisms associated with this process are undoubtedly complicated, and the role of viral endonucleases in the fate of AU-rich mRNAs is worth further study. It is unclear whether SOX/muSOX proteins need host or viral proteins to target transcripts. We further speculate that these proteins may play role in other cellular and host processes to promote survival, which should aid in elucidating the mechanisms of herpesviruses host shutoff. In summary, a better understanding of host shutoff proteins not only provides new insights into the viral replication, expression and immune evasion process, but also contributes to provide new molecular targets for the development of antiviral drugs and therapies.